Relationship between stages of diabetic retinopathy and levels of brain-derived neurotrophic factor in aqueous humor and serum

Uzel A. G. T., UĞURLU N., TOKLU Y., Cicek M., BORAL B., ŞENER B., ...More

Retina, vol.40, no.1, pp.121-125, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 40 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.1097/iae.0000000000002355
  • Journal Name: Retina
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Page Numbers: pp.121-125
  • Keywords: brain-derived neurotrophic factor, diabetes mellitus, diabetic retinopathy, POTENTIAL RISK-FACTORS, FACTOR BDNF, MACULAR EDEMA, NEURODEGENERATION
  • Lokman Hekim University Affiliated: No


© 2020 Lippincott Williams and Wilkins. All rights reserved.Purpose: The aim of the study was to determine aqueous humor and serum levels of brain-derived neurotrophic factor (BDNF) in diabetic patients with and without retinopathy. Methods: The study included diabetic patients with or without retinopathy, who had an indication for cataract surgery. The study groups were diabetic patients without retinopathy (Group 2), with nonproliferative diabetic retinopathy (Group 3), and with proliferative retinopathy (Group 4). To quantitatively determine the amount of BDNF in samples, the RayBio Human BDNF ELISA kit (Norcross, GA), based on an enzyme-labeled immunosorbent assay was used. Results: The median serum BDNF levels were significantly lower in all the study groups than in the control group (P values: 0.038 Group 2, 0.02 Group 3, and 0.002 Group 4). Serum BDNF was lower in Group 4 than in Group 3 (P = 0.030), and in Group 3 than in Group 2 (P = 0.04). The median aqueous humor BDNF levels were significantly decreased in all groups (P values: 0.047 Group 2, 0.021 Group 3, and 0.007 Group 4). There was no significant difference between Groups 2, 3, and 4 (P = 0.214). Conclusion: The serum and aqueous humor BDNF levels decreased in patients with diabetes mellitus (DM) before the emergence of clinical signs of retinopathy.